U.S. Markets open in 5 hrs 52 mins

GlycoMimetics, Inc. – Value Analysis (NASDAQ:GLYC) : October 17, 2017

CapitalCube
Capital Cube
GlycoMimetics, Inc. – Value Analysis (NASDAQ:GLYC) : October 17, 2017

Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives GlycoMimetics, Inc. a score of 21. Our analysis is based on comparing GlycoMimetics, Inc. with the following peers – bluebird bio, Inc., Sanofi Sponsored ADR, Eiger BioPharmaceuticals, Inc., Savara, Inc., Pfizer Inc., Palatin Technologies, Inc. and Johnson & Johnson (BLUE-US, SNY-US, EIGR-US, SVRA-US, PFE-US, PTN-US and JNJ-US). ... Read more (Read more...)